Condition: Arthritis, Psoriatic · Sponsor: MoonLake Immunotherapeutics AG
This is a study to confirm the clinical efficacy and safety of sonelokimab compared with placebo in the treatment of adults with active psoriatic arthritis who have had a previous inadequate response or intolerance to anti-tumor necrosis factor (TNF)α therapy.
This description comes directly from the study's public registry record.
Moonlake Clinical Trial Helpdesk · +41 41 510 8022 · ClinicalTrials@moonlaketx.com
Always discuss trial participation with your own doctor first.
| Clinical Site | Avondale, Arizona, United States | Recruiting |
| Clinical Site | Chandler, Arizona, United States | Completed |
| Clinical Site | Flagstaff, Arizona, United States | Completed |
| Clinical Site | Mesa, Arizona, United States | Recruiting |
| Clinical Site | Phoenix, Arizona, United States | Recruiting |
| Clinical Site | Scottsdale, Arizona, United States | Recruiting |
| Clinical Site | Tucson, Arizona, United States | Recruiting |
| Clinical Site | Jonesboro, Arkansas, United States | Recruiting |
| Clinical Site | La Jolla, California, United States | Recruiting |
| Clinical Site | Pomona, California, United States | Recruiting |
| Clinical Site | San Diego, California, United States | Recruiting |
| Clinical Site | Santa Monica, California, United States | Recruiting |
+ 127 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06641089